214 related articles for article (PubMed ID: 30551703)
1. Reassortment of bluetongue virus vaccine serotypes in cattle.
Van den Bergh C; Coetzee P; Venter EH
J S Afr Vet Assoc; 2018 Dec; 89(0):e1-e7. PubMed ID: 30551703
[TBL] [Abstract][Full Text] [Related]
2. Viral replication kinetics and in vitro cytopathogenicity of parental and reassortant strains of bluetongue virus serotype 1, 6 and 8.
Coetzee P; Van Vuuren M; Stokstad M; Myrmel M; van Gennip RG; van Rijn PA; Venter EH
Vet Microbiol; 2014 Jun; 171(1-2):53-65. PubMed ID: 24685608
[TBL] [Abstract][Full Text] [Related]
3. Emergence of a Novel Reassortant Strain of Bluetongue Serotype 6 in Israel, 2017: Clinical Manifestations of the Disease and Molecular Characterization.
Golender N; Eldar A; Ehrlich M; Khinich Y; Kenigswald G; Varsano JS; Ertracht S; Abramovitz I; Assis I; Shlamovitz I; Tiomkin E; Yonay E; Sharir B; Bumbarov VY
Viruses; 2019 Jul; 11(7):. PubMed ID: 31295819
[TBL] [Abstract][Full Text] [Related]
4. Full genome sequence of the first bluetongue virus serotype 21 (BTV-21) isolated from China: evidence for genetic reassortment between BTV-21 and bluetongue virus serotype 16 (BTV-16).
Qin S; Yang H; Zhang Y; Li Z; Lin J; Gao L; Liao D; Cao Y; Ren P; Li H; Wu J
Arch Virol; 2018 May; 163(5):1379-1382. PubMed ID: 29392498
[TBL] [Abstract][Full Text] [Related]
5. Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines.
Celma CC; Stewart M; Wernike K; Eschbaumer M; Gonzalez-Molleda L; Breard E; Schulz C; Hoffmann B; Haegeman A; De Clercq K; Zientara S; van Rijn PA; Beer M; Roy P
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795442
[TBL] [Abstract][Full Text] [Related]
6. A European field strain of bluetongue virus derived from two parental vaccine strains by genome segment reassortment.
Batten CA; Maan S; Shaw AE; Maan NS; Mertens PP
Virus Res; 2008 Oct; 137(1):56-63. PubMed ID: 18598726
[TBL] [Abstract][Full Text] [Related]
7. Rapid generation of replication-deficient monovalent and multivalent vaccines for bluetongue virus: protection against virulent virus challenge in cattle and sheep.
Celma CC; Boyce M; van Rijn PA; Eschbaumer M; Wernike K; Hoffmann B; Beer M; Haegeman A; De Clercq K; Roy P
J Virol; 2013 Sep; 87(17):9856-64. PubMed ID: 23824810
[TBL] [Abstract][Full Text] [Related]
8. Field-Reassortment of Bluetongue Virus Illustrates Plasticity of Virus Associated Phenotypic Traits in the Arthropod Vector and Mammalian Host
Sanders C; Veronesi E; Rajko-Nenow P; Mertens PPC; Batten C; Gubbins S; Carpenter S; Darpel K
J Virol; 2022 Jul; 96(13):e0053122. PubMed ID: 35727032
[TBL] [Abstract][Full Text] [Related]
9. Evolution of bluetongue virus serotype 1 in northern Australia over 30 years.
Boyle DB; Amos-Ritchie R; Broz I; Walker PJ; Melville L; Flanagan D; Davis S; Hunt N; Weir R
J Virol; 2014 Dec; 88(24):13981-9. PubMed ID: 25253345
[TBL] [Abstract][Full Text] [Related]
10. Vaccines against bluetongue in Europe.
Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
[TBL] [Abstract][Full Text] [Related]
11. VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA.
Feenstra F; Maris-Veldhuis M; Daus FJ; Tacken MG; Moormann RJ; van Gennip RG; van Rijn PA
Vaccine; 2014 Dec; 32(52):7108-14. PubMed ID: 25454873
[TBL] [Abstract][Full Text] [Related]
12. A synthetic biology approach for a vaccine platform against known and newly emerging serotypes of bluetongue virus.
Nunes SF; Hamers C; Ratinier M; Shaw A; Brunet S; Hudelet P; Palmarini M
J Virol; 2014 Nov; 88(21):12222-32. PubMed ID: 25142610
[TBL] [Abstract][Full Text] [Related]
13. The Bluetongue Disabled Infectious Single Animal (DISA) Vaccine Platform Based on Deletion NS3/NS3a Protein Is Safe and Protective in Cattle and Enables DIVA.
van Rijn PA; Maris-Veldhuis MA; van Gennip RGP
Viruses; 2021 May; 13(5):. PubMed ID: 34067226
[TBL] [Abstract][Full Text] [Related]
14. Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle.
Hamers C; Galleau S; Chery R; Blanchet M; Besancon L; Cariou C; Werle-Lapostolle B; Hudelet P; Goutebroze S
Vet Rec; 2009 Sep; 165(13):369-73. PubMed ID: 19783850
[TBL] [Abstract][Full Text] [Related]
15. Recent US bluetongue virus serotype 3 isolates found outside of Florida indicate evidence of reassortment with co-circulating endemic serotypes.
Schirtzinger EE; Jasperson DC; Ostlund EN; Johnson DJ; Wilson WC
J Gen Virol; 2018 Feb; 99(2):157-168. PubMed ID: 29120297
[TBL] [Abstract][Full Text] [Related]
16. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
Feenstra F; Pap JS; van Rijn PA
Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
[TBL] [Abstract][Full Text] [Related]
17. [Genetic diversity analysis of the S10 gene of field and vaccine strains of Bluetongue virus].
Zhang Y; Zhang N; Liu J; Zhu J; Yin Z
Wei Sheng Wu Xue Bao; 2003 Dec; 43(6):698-705. PubMed ID: 16276888
[TBL] [Abstract][Full Text] [Related]
18. Differentiation between field and vaccine strain of bluetongue virus serotype 16.
Monaco F; Cammà C; Serini S; Savini G
Vet Microbiol; 2006 Aug; 116(1-3):45-52. PubMed ID: 16713688
[TBL] [Abstract][Full Text] [Related]
19. Complete genome sequence of the first bluetongue virus serotype 7 isolate from China: evidence for entry of African-lineage strains and reassortment between the introduced and native strains.
Yang H; Lv M; Sun M; Lin L; Kou M; Gao L; Liao D; Xiong H; He Y; Li H
Arch Virol; 2016 Jan; 161(1):223-7. PubMed ID: 26497176
[TBL] [Abstract][Full Text] [Related]
20. Identification of seven serotypes of bluetongue virus from the People's Republic of China.
Zhang N; MacLachlan NJ; Bonneau KR; Zhu J; Li Z; Zhang K; Zhang F; Xia L; Xiang W
Vet Rec; 1999 Oct; 145(15):427-9. PubMed ID: 10755588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
